In four patients, we identified four disease-causing genes, of which variants in PDHB, MTPAP, and SUCLA2 have been reported not as a cause of CMT but of other diseases associated with symptomatic or subclinical peripheral neuropathy [14–16]. This evidence concerns the gene SUCLA2 and peripheral neuropathy.